RT Journal Article
SR Electronic
T1 Induction of Estrogen Receptor α Expression with Decoy Oligonucleotide Targeted to NFATc1 Binding Sites in Osteoblasts
JF Molecular Pharmacology
JO Mol Pharmacol
FD American Society for Pharmacology and Experimental Therapeutics
SP 1457
OP 1462
DO 10.1124/mol.107.034561
VO 71
IS 6
A1 Letizia Penolazzi
A1 Margherita Zennaro
A1 Elisabetta Lambertini
A1 Elisa Tavanti
A1 Elena Torreggiani
A1 Roberto Gambari
A1 Roberta Piva
YR 2007
UL http://molpharm.aspetjournals.org/content/71/6/1457.abstract
AB The nuclear factor of activated T cell cytoplasmic 1 (NFATc1) is a member of the NFAT family and is strictly implicated in the growth and development of bone. Most studies have focused on the effects of NFATc1 activation on osteoclastogenesis. On the contrary, the specific roles of NFAT in osteoblast differentiation are not well understood and, in some instances, reports of its role are contradictory. In the present study, we demonstrated that NFATc1 was involved in the transcriptional regulation of human estrogen receptor α (ERα) gene in SaOS-2 osteoblastic like cells. NFATc1 was specifically recruited “in vivo” at C and F distal promoters of ERα gene. In addition, it is here identified as the negative transcription factor removed by the RA4-3′decoy oligonucleotide able to induce ERα expression in osteoblasts. Ca2+/calcineurin-NFAT-mediated signaling pathways and ERα-dependent signals are involved in diverse cellular reactions by regulating gene expression under both physiological and pathological conditions. Therefore, our data might be useful for proper manipulation of NFATc1- and ERα-mediated cellular reactions in different bone disorders, such as osteoporosis. The American Society for Pharmacology and Experimental Therapeutics